четверг, 15 марта 2012 г.

Dutch crime reporter to unveil result of undercover Natalee Holloway investigation

A Dutch crime reporter on Sunday was revealing the results of a five-month undercover investigation he claims will solve the mysterious May 2005 disappearance of American teen Natalie Holloway on the Caribbean island of Aruba.

Holloway vanished just before she was due to fly home to Mountain Brook, Alabama, at the end of her high school graduation trip. No trace of her has been seen since.

Peter R. de Vries will outline his version of events in a two-hour show that includes hidden camera recordings of Dutch student Joran van der Sloot, a former suspect who denies any involvement in Holloway's disappearance. American network ABC has bought the rights to the …

Student president resigns after DUI: ; WVU leader arrested over the weekend

West Virginia University's Student Government Associationpresident has resigned after being arrested for driving under theinfluence over the weekend.

"I cannot let my defense against those charges interfere with thegoals and missions" of student government, David Kirkpatrick said ina letter he hand delivered Tuesday to The Daily Athenaeum, WVU'sstudent newspaper.

Current Vice President Jason Parsons will become president. Vice-chair Milisa Cutlip will be the new vice president. The judicialboard was to swear them in this morning during a closed ceremony.

The DUI charge could have consequences inside and outside theuniversity. An SGA member said Kirkpatrick …

Korea's Daewoo buys SsangYong Motors

Daewoo acquired a majority stake in debt-ridden SsangYong Motors. The deal could signal the start of a major shakeout of the Korean motor industry. The departure of SsangYong reduces the number of automakers in Korea to four, but analysts say even that could be too many. The sale has also been criticized because of the favorable terms granted by the government, which gives Daewoo 10 years to pay off SsangYong Motors' $1.6 billion of debt.

The deal, however, is a perfect fit, giving Daewoo a range of different vehicles including 4x4s, vans, trucks and the new Chairman limousine, based on the old Mercedes E-Class. Daewoo is keeping the businesses separate for now, but will likely …

среда, 14 марта 2012 г.

Sanofi, AstraZeneca paths diverge in 2nd quarter

Two of Europe's largest drug firms Thursday issued brighter forecasts for earnings growth this year despite reporting second quarter results that highlighted their diverging fortunes in the face of competition from generics and the weakening of the U.S. dollar.

France's Sanofi-aventis SA lifted its forecast for earnings per share growth this year to 8 percent from its previous target of around 7 percent, while rival British drug maker AstraZeneca PLC upped its target range for core 2008 EPS to between US$4.60 and US$4.90. Britain's second-largest drug maker behind GlaxoSmithKline PLC had previously forecast 2008 EPS between US$4.40 and US$4.70.

Like other …

'30 days of hell' for US victim of German E. coli

ATLANTA (AP) — In early May, John Meyer stayed at a lakeside hotel in Hamburg, Germany. He attended a business conference. He went sailing. And he became one of the few U.S. victims in one of the worst food poisoning outbreaks in recent world history.

Meyer went to the hospital a week later with what turned out to be a rare and deadly strain of E. coli bacteria that caused thousands of illnesses, mostly in Germany. He would spend the next month in a Massachusetts hospital, much of the time a delirium, while doctors worked around the clock to save his life.

Meyer is one of six U.S. cases linked to the German outbreak and he's the first to talk about his terrible experience, …

Manolo Martinez, 50, famous matador

MEXICO CITY Manolo Martinez, 50, the champion of Mexicanbullrings in the 1960s and 1970s, died Friday while awaiting a kidneytransplant, Mexican news media said. He was 50.

Mr. Martinez, one of the greatest Mexican matadors of all time,was known at the height of his career as "the Chief of the BraveFestival."

In the Plaza Mexico, the world's biggest bullring, Mr. Martinezwon 10 bull tails …

Mariah Carey, Nick Cannon parents of twins

NEW YORK (AP) — Mariah Carey and Nick Cannon celebrated their third anniversary with another milestone — becoming parents to a baby girl and boy.

Carey's representative, Cindi Berger, confirmed the births to The Associated Press. The singing superstar gave birth Saturday at 12:07 p.m. EDT (1607 GMT) at an undisclosed hospital in Los Angeles. Berger says the baby girl was born first, weighing 5 pounds, 3 ounces (2.35 kilograms), and was 18 inches (45.7 centimeters) tall; her brother was next, at 5 pounds 6 ounces (2.44 kilograms), and was 19 inches (48.3 centimeters).

Berger says the couple has not named the children yet. Cannon drove Carey to the hospital in their Rolls-Royce …

16 Russian tourists killed in Turkey bus crash

A bus carrying Russian tourists skidded off a highway in southern Turkey and fell off a bridge Tuesday, killing 16 passengers and injuring 25 others, officials and news reports said.

The bus flipped over and fell about 20 feet (six meters) onto a river bed, NTV television footage showed. Deputy Gov. Mehmet Seyman of the Mediterranean province of Antalya said rescue workers struggled to pull the bodies and injured from the wreckage.

NTV television, citing local authorities, said the driver was sleeping at the wheel.

Each year, thousands of people are …

Local Sports

Poca sophomore sharp in defeat

Poca High sophomore goalkeeper Jessica Coleman was up to the taskThursday, stopping 12 Point Pleasant shots.

However, a goal off a rebound by Point Pleasant's Shawna Drain inthe 65th minute was the difference in the game as the visiting BigBlacks (9-2-1) escaped with a 1-0 victory in girls soccer action.

"This was by far our best game of the year," Poca Coach Jim Hallsaid. "It was a heck of a game. We fell just a tad short but it was aterrific team effort."

Poca (4-11) had one last chance to tie the game inside of a minuteto play, getting the ball inside Point Pleasant's penalty box, butcouldn't score.

"I'm proud we …

Scientists say cut soot, methane to curb warming

WASHINGTON (AP) — An international team of scientists says it has figured out how to slow global warming in the short run and prevent millions of deaths from dirty air. And they say their proposals would save more money than it would cost.

These experts say the key is cutting emissions of two powerful causes of global warming — methane and soot. Methane is produced by landfills, farms and energy …

Bar-Illan, David (Jacob)

Bar-Illan, David (Jacob)

Bar-Illan, David (Jacob), Israeli pianist; b. Haifa, Feb. 7, 1930. He studied at the Haifa Music Inst., and then in N.Y. at the Juilliard School of Music and the Mannes Coll. of Music. In 1946 he made his debut as a soloist with the Palestine Broadcasting Service Orch. After an engagement at London's Wigmore Hall in 1953, he played in the U.S. in 1954. Thereafter he appeared as a soloist with orchs. and …

INTERIM

I was at the Tamarack Grand Prix over the weekend with a B W team. It was my first time at Tamarack, and I was impressed. It was truly a winter wonderland treat. Everyone we met was genuinely helpful and friendly, and it was great …

Vivendi 4th-quarter net loss narrows 32 pct

Vivendi SA said Monday its net loss narrowed by 32 percent in the fourth quarter due to lower financial charges, even though it made a euro550 million ($746 million) provision to cover possible fines from a U.S. class action suit brought by shareholders.

The French media and entertainment giant added in a statement that the amount of damages it might have to pay "could differ significantly" from the euro550 million provision after a jury in the United States said Vivendi lied to the public about its shaky finances.

Vivendi said its net loss in the fourth quarter of last year was euro958 million ($1.3 billion) compared with euro1.4 billion a year earlier, thanks to lower financial charges.

The company was found liable for lying about its finances in a January verdict in U.S. District Court in Manhattan.

Vivendi has said it will appeal.

In Monday's statement, chairman Jean-Bernard Levy said Vivendi will "continue to vigorously defend the company and its current shareholders against the unfounded claims we and they are suffering."

Lawyers on both sides said any potential payouts if the appeal fails are more than a year away.

Thousands of investors from the United States, France, England and the Netherlands said Vivendi covered up its troubles in 2001 and 2002 as the one-time public water company grew into a media and communications empire. The company flirted with bankruptcy before reorganizing successfully.

Vivendi's media and entertainment holdings include the world's largest music company, Universal Music Group, and pay television service Canal Plus. It also owns SFR, the French mobile telecommunications operator, and Santa Monica, Calif.-based Activision Blizzard, the video game producer behind titles such as "Call of Duty" and "World of Warcraft."

Last year, Vivendi agreed to sell its 20 percent stake in U.S. media giant NBC Universal for $5.8 billion to General Electric Co. Now, GE and Philadelphia-based Comcast Corp. plan to form a joint venture, with Comcast eventually taking a 51 percent stake in the business.

Vivendi also lbought Brazilian telecom operator GVT last year for euro2.8 billion.

Vivendi's fourth quarter loss left its net profit for the full year at euro830 million, down 68 percent from euro2.6 billion in 2008, due to higher financial charges.

The company's underlying profit, which excludes most non-recurring and non-operating items and is the measure watched most closely by financial analysts, fell 5.5 percent last year to euro2.59 billion.

Universal Music Group, behind acts such as Black Eyed Peas, Taylor Swift and Lady Gaga, saw earnings and sales slide last year as free music downloads continued to eat into CD sales.

SFR, France's No. 2 mobile operator saw earnings stagnate despite slightly higher revenue last year due to new taxes and lower inter-operator fees. New regulations in some of the operators' biggest markets lowered the fees operators pay one another to send calls over each others' networks.

вторник, 13 марта 2012 г.

US appeals court: Once al-Qaida, always al-Qaida?

WASHINGTON (AP) — U.S. appeals court judges deciding whether to release a Guantanamo Bay detainee asked Friday: If once an al-Qaida member, always an al-Qaida member?

The Obama administration has appealed an order for the release of Mohamedou Ould Salahi, who has been accused of helping recruit Sept. 11 hijackers. A lower court judge said Salahi should be freed because he was abused by interrogators at the Naval-run prison in Cuba and later retracted his confession to arranging travel for two hijackers.

Salahi admits he joined al-Qaida in the early 1990s to fight communists in Afghanistan. But he says he stopped fighting for the organization before it turned against the United States.

The Sept. 11 commission report described Salahi as a significant al-Qaida operative who instructed hijackers how to reach Afghanistan to train for jihad. In court filings, the Justice Department says in October 1999, Salahi encouraged Ramzi bin al Shibh, Marwan al Shehhi and Ziad Jarrah to join. Al Shehhi and Jarrah became two of the hijackers and Bin al Shibh helped coordinate the Sept 11 plot.

Salahi was arrested in his home country of Mauritania 18 days after the terrorist attacks of Sept. 11, 2001. His lawyers say he was sent to Jordan and abused for eight months before being moved to Bagram Air Field in Afghanistan and finally to Guantanamo in 2002.

U.S. District Judge James Robertson ruled this spring that the evidence against Salahi was "tainted by coercion and mistreatment" and based on classified material that could not support a criminal prosecution.

Salahi's treatment was documented in a 2009 report by the Senate Armed Services Committee that investigated allegations of detainee abuse at Guantanamo. It described how in July 2003, Salahi was isolated, questioned by a masked interrogator, forced to stand for long periods of time, threatened with death and torture and exposed to flashing strobe lights and the blaring metal song "Bodies" by Drowning Pool.

The Justice Department acknowledges that much of the evidence against Salahi is tainted and said instead that it is relying on his statements some time after the abuse ended and other evidence against him. Justice Department attorney August Flentje told a three-judge panel with the U.S. Court of Appeals in Washington Friday that Salahi's pledge to support al-Qaida and his continuing association with other members mean he remained part of the terrorist organization.

But Flentje faced skepticism, particularly from Judge David Tatel, who questioned whether Salahi's swearing of an Islamic oath, or "bayat," to al-Qaida 10 years before the Sept. 11 attacks is evidence that he engaged in hostilities against the United States.

"When he swore bayat, the United States and al-Qaida had a common goal," said Tatel, who was appointed by President Bill Clinton. "Both the United States and al-Qaida were opposing a communist government of Afghanistan."

Flentje argued that Salahi's continued association with al-Qaida members proved he did not leave the group. Salahi admits that he stayed in touch with friends who continued to support al-Qaida, including his brother-in-law, who was a high-ranking spiritual adviser to al-Qaida leader Osama bin Laden.

But David Sentelle, chief judge of the court and an appointee of Ronald Reagan, said it would not be expected that Salahi would completely sever ties with al-Qaida. "That's going to get him killed," Sentelle said.

Still, Tatel suggested that it might be appropriate to send Salahi's case back to the lower court considering subsequent decisions in other Guantanamo Bay cases that have set new legal standards since Robertson ruled in March. Robertson has since retired so that would mean reassigning the case to a new judge.

China's State Food and Drug Administration Discusses Drug Applications

A Q&A with officers of the departments of State Food and Drug Administration, China

In this interview, Ji Xie, President, Chinese Operations, Advanced Pharmaceuticals, moderates a Q&A with officers of the departments of State Food and Drug Administration (SFDA), China.

Xie: Can you provide me with a brief overview of SFDA application and approval of foreign drugs?

SFDA: Drug registration applications include applications for new drugs, generic drugs, imported drugs and their supplementary applications, as well as re-registration applications. To apply for an import drug registration, the applicant shall fill out the Application Form for Drug Registration, submit relevant dossiers and samples, provide relevant approval documents, and submit the application to the State Food and Drug Administration.

Xie: What is the standard application procedure for an imported drug?

SFDA: Application for an imported drug refers to the registration application for drugs manufactured abroad to be marketed within the territory of the People's Republic of China. A drug being applied for importation shall have already obtained the drug marketing authorization in the producing country or region where the overseas pharmaceutical manufacturer is located; those that have not yet obtained marketing authorization in the producing country or region, may still be approved for importation by the State Food and Drug Administration if they can confirm safety and efficacy through clinical trials.

Xie: What is the application for a generic drug?

SFDA: The generic drug shall have the identical active ingrethents, route of administration, dosage form, strength, and therapeutic effects as a registered drug. When a drug has been produced by more than one manufacturer, the selection of registered drugs for comparative study shall be in accordance with relevant technical guidelines.

Xie: Who should file an application for an imported drug registration?

SFDA: An overseas applicant applies for an imported drug registration, which shall be done by its branch in China or an entrusted agency within the territory of People's Republic of China. The people who handle the application for drug registration must have professional knowledge and be familiar with the laws and regulations on, and the technical requirements for, drug registration.

Xie: What is required to provide in the application?

SFDA: The applicant shall provide sufficient and reliable research data to prove the safety, efficacy, and quality of the drug, and be liable for the authenticity of all the dossiers submitted. The cited literature of the dossier of drug registration shall indicate the title of works or the name, volume number, issue, and page of the journal. Where the cited references are not published, an author's permission shall be provided. For foreign literatures, Chinese translation shall be provided as required.

Xie: What are the application and approval procedures for a foreign drug?

SFDA: The approval procedures can be divided into the approval of clinical trial and approval of imported drug application.

For Approval of clinical trials, four steps are involved

a. Application submission and review by SFDA (timeline: 30 days). It is important to submit the application in the format that SFDA requires. Once the application is received, SFDA will check the dossier content and format and send notification of quality test and specifications verification conducted by National Institute for the Control of Pharmaceutical and Biological Products (NICPBP) (timeline: 85 days).

b. Technical Evaluation by the Center of Drug Evaluation (timeline: 90 days)

c. Final Decision by SFDA (timeline: 30 days)

d. If approved, Notification of Clinical trial protocol and the list of investigators to SFDA.

For the approval of an imported drug application, three steps are involved:

a. Submission of clinical trial results and other amended or supplemental data by applicant

b. Technical evaluation by the Center of Drug Evaluation (timeline: 150 days)

c. Final Decision by SFDA (timeline: 30 days)

The timeline for drug registration in the Provisions refers to the maximum time for acceptance, review, and approval of drug registration. The time for the suspension of the review and approval prescribed in laws and regulations or for the applicant to supplement data is not included.

Xie: What are the difficulties involved in handling the application and approval of a foreign drug in China?

SFDA: The First difficulty involves the lack of familiarity with the laws and regulations in China. The success of handling an application of import drugs registration depends on the person or agent's familiarity of the laws and regulations on drug registration in China. The applicant should realize the difference between laws and regulations of drug registration in China and other countries in order to well prepare the applications according to the laws and regulations in China.

Xie: Can you tell me what is involved in the preparation of an application?

SFDA: The dossier for drug registration application shall be submitted at one time. No other technical materials should be added by the applicant after a drug registration application is accepted, with the exception of applications for special review and approval, new findings regarding drug safety, or supplementary materials that are requested. Also, It is required that all the materials including dossier and references in a language other than Chinese be translated in Chinese. The accurate translation is also a key factor in the approval of an application.

Xie: What types of applications and indications for foreign drug approval are encouraged?

SFDA: The State encourages the research and development of new drugs and adopts the special review and approval with respect to innovative drugs, new drugs for serious and life-threatening diseases, and to address unmet medical needs and drugs. An application for new drugs refers to an application for registration of drugs that have not been marketed within the territory of People's Republic of China.

a. Active ingrethents extracted from plants, animals, and minerals, etc. and their preparations not yet marketed in China

b. Chemical drug substances and their preparations and biological products not yet approved for marketing in China or abroad

c. New drugs for the treatment of diseases such as AIDS, malignant tumors, and rare diseases, etc. with significant clinical advantage

d. New drugs for the treatment of diseases, for which effective therapeutic methods are not available.

Xie: Drugs with what technology platforms are simpler to receive approval in China?

SFDA: The SFDA encourages applications with new and advanced technologies and products with new technologies that have demonstrated efficacy, safety, and clinical needs.

a. Advanced technology and industrialization in pharmaceutical preparations

b. Advanced technology and industrialization in natural medicine and traditional Chinese medicine (TCM)

c. Advanced technology in bio/ pharmaceutical research and development and industrialization

d. Advanced technology in smallmolecule drug research and development and industrialization.

Xie: Are there common issues that arise in the application and approval of a foreign drug, and how can one overcome them?

SFDA: The most common issue in an application of an imported drug registration is preparation of the application. This heavily depends on the familiarity of laws and regulations on drug registration in China. Due to the differences of laws and regulations in different countries, the applicant must realize the requirements of application submission are different, and the applicant must meet all the requirements listed in the regulation. To overcome this issue, the applicant should

1. Get familiar with the laws and regulations for drug registration in China

2. Prepare the dossier and related materials according to the regulations

3. Keep good communications open with your agents in China as well the SFDA to get updates of changes in laws and regulations.

Xie: How does SFDA work with the Chinese Pharmacopoeia Commission?

SFDA: The Chinese Pharmacopoeia Commission is directly affiliated with SFDA and is responsible for

a. Compiling the Pharmacopoeia of The People's Republic of China

b. Establishing the state drug standard, packing material standard, equipment, and pharmaceutical excipients standard

c. Conducting state drug standard in testing phase in order to finalize the drug standard of China

d. Providing training and consulting for the state drug standard

e. Establishing standard information systems for state drug standard, participating in international exchanges and collaboration of drug standard

f. Publishing the Journal of State Drug Standards and other drugstandard-related publications

g. Any additional tasks assigned by SFDA.

US manufactures can find information about the Chinese Pharmacopoeia from the SFDA website or Chinese Pharmacopoeia Commission at www.chp.org.cn (only Chinese version is currently available).

Xie: How does SFDA work with the newly created International Pharmaceutical Excipients Council (IPEC) in China?

SFDA: IPEC-China was established in 2008 as a nonprofit organization. IPEC-China members are from pharmaceutical excipient manufacturers, users, and distributors. IPECChina can assist with the SFDA and Chinese Pharmacopoeia Commission to improve safety of excipient application and guarantee public safety.

Xie: Where should manufacturers submit an application for review? To whom at SFDA and to what address should applications be submitted?

SFDA: Reception Center State Food and Drug Administration Address: A38, Beilishi Road, Beijing 100810, P.R. China

Office Hour: 8:30-11:30 am/13:00-16:00; Tel: 010 - 68315572; Fax: 010-88330265; e-mail: slzx@sfda.gov.cn.

Xie: Can applications be submitted electronically, and if so, is there a templated form?

SFDA: Applicantants must use the software provided by SFDA to file an application. Both electronic files and hard copy must be submitted to The Reception Center at SFDA.

Xie: Do submissions need to be in Chinese?

SFDA: Yes, All submissions need to be in Chinese.

Xie: Is there a website where manufacturers outside of China can get contact information as well as more general information about SFDA and its drug approval/marketing process?

SFDA: Yes, the website of Reception Center (to download application, submit applications, and check the status of an application): http://www.sfda.gov.cn/ WS01/CL0399/.

Xie: Is there any literature available that advises foreign manufacturers on the processes and procedures involved in submitting drug applications? Where/ how can people obtain this literature?

SFDA: Literature is available at the website of the Reception Center: http://www.sfda.gov.cn/ WS01/CL0147/. You can also check SFDA Order No. 28 (Provisions of Drug Registration) http://eng.sfda.gov.cn/cmsweb/ webportal/W45649039/ A64028429.html.

Xie: What is SFDA's working relationship with the US FDA, which now has offices in Beijing, Shanghai, and Guangzhou?

SFDA: SFDA is an important strategic partner of the USA. Both parties reached a consensus in 2007 on further expanding the exchange and cooperation between the food and drug regulatory departments of the two countries, hoping to conduct indepth communication in the application of new technologies, guidelines of supervision, future strategic planning, and other aspects. Both parties are cooperating in the fields of pharmaceutical and biological products, and US FDA provides assistance in technical support and capacity building.

[Sidebar]

*This is the first in an ongoing series of interviews to he conducted by Advanced Pharmaceuticals, LLC, an international business engaged in technology transfer to China, licensing of drugs to China, and obtaining SFDA approvals for drugs and devices in China. This interview was translated by Ji Xie and Feng Li and edited by John R. Choate, all of Advanced Pharmaceuticals .

Jim & Louella's Homemade Heart-Fix Remedy

Jim & Louella's Homemade Heart-Fix Remedy by Bertice Berry Harlem Moon/Broadway Books September 2003 $11.95, ISBN 0-767-90989-5

After 26 years of marriage, Jim and Louella's love life has become somewhat routine. One night, Jim experiences an episode of impotence. Louella calls on her female ancestors for help. Her mother, grandmother and aunt come to Louella in her dreams, and give her some sage and humorous advice. Louella follows their instructions, and in short time, things between Jim and Louella take a decidedly hot and steamy turn.

At the same time, they discover that they have been given a new gift-a gift that has far-reaching and long-lasting effects on the entire community. Jim and Louella begin to hear the thoughts of their neighbors and see into their deepest secrets and fears. They also develop the ability to feel what others are feeling. Armed with this gift, the couple starts to help their neighbors, and before long, they have people coming to their door for some heart fixing. Their advice is delivered in a distinctly folksy manner with good old-fashioned common sense combined with a healthy dose of humor.

As the story unfolds, Jim and Louella learn that all that has happened to them is not coincidental, but part of a larger picture involving African American history, tradition and spirituality. Using her unique style of telling a story, Bertice Berry (Redemption Song, Doubleday 2000, and The Haunting of Hip Hop, Doubleday 2001) delivers a heartwarming, funny and touching story of love and history, complete with a wonderful cast of characters and a memorable, thought-provoking story line. A bonus is the Reading Group Companion section at the end of the novel, featuring 10 questions sure to stimulate a lively discussion of the book.

[Author Affiliation]

Reviewed by Mary N. Oluonye Mary N. Oluonye is a writer in Cleveland, Ohio. She is a library associate at the Shaker Heights Public Library.

Ca^sup 2+^-Triggered Simultaneous Membrane Penetration of the Tandem C2-Domains of Synaptotagmin I

ABSTRACT

Synaptotagmin I (syt), a transmembrane protein localized to secretory vesicles, functions as a Ca^sup 2+^ sensor that facilitates SNARE-mediated membrane fusion. The cytoplasmic domain of syt harbors two C2-domains designated C2A and C2B. Upon binding Ca^sup 2+^, C2A and C2B partially penetrate into membranes that contain anionic phospholipids. However, it is unknown whether these tandem C2-domains engage membranes at the same time, in a sequential manner, or in a mutually exclusive manner. We have used site-directed fluorescent probes to monitor the penetration of syt's C2-domains into phosphatidylserine-harboring lipid bilayers. We report that, in response to Ca^sup 2+^, C2A and C2B copenetrate into these bilayers with diffusion-limited kinetics. Membrane penetration was more efficient when synthetic rather than natural phospholipids were used to prepare bilayers. The membrane penetration activity of the intact cytoplasmic domain of syt (C2A-C2B) exhibits significant resistance to changes in ionic strength. In contrast, the ability of isolated C2B to bind membranes in response to Ca^sup 2+^ can be disrupted by subtle changes in ionic strength. Tethering C2B to a mutant version of C2A that does not bind Ca^sup 2+^ or membranes significantly increases the stability of Ca^sup 2+^.C2B.membrane complexes, confirming that C2A affects the membrane-binding properties of the adjacent C2B domain.

INTRODUCTION

Exocytosis of neurotransmitter is an extremely rapid process that is triggered by influx of Ca^sup 2+^ through voltage-activated Ca^sup 2+^ channels (1-3). The molecular identity of Ca^sup 2+^ sensors that regulate secretion and the molecular mechanism by which these sensors couple Ca^sup 2+^ to the opening of fusion pores are issues that have attracted considerable attention (4). A substantial body of evidence suggests that synaptotagmins, a family of transmembrane proteins localized to secretory vesicles, play critical roles in coupling Ca^sup 2+^ to exocytosis. In particular, synaptotagmin I (syt), the best-characterized member in the family, likely serves as the Ca^sup 2+^ sensor for rapid neurotransmitter release at synapses (4-6).

Syt harbors a short N-terminal luminal domain, a single transmembrane domain, and a large cytoplasmic domain composed of tandem C2-domains, designated C2A and C2B (7,8). It is well established that in response to Ca^sup 2+^, C2A binds tightly and rapidly to membranes harboring anionic phospholipids, such as phosphatidylserine (PS) (9,10). Two Ca^sup 2+^-binding loops of C2A (loop 1 and 3) partially penetrate into lipid bilayers, forming a tripartite complex-Ca^sup 2+^ . C2A.membrane-in which anionic phospholipid head-groups probably complete the Ca^sup 2+^-binding sites to increase the apparent affinity of C2A for Ca^sup 2+^ (10-13). C2B is structurally similar to C2A (14) and also functions as a Ca^sup 2+^-sensing module (15); however, the biochemical properties of C2A and C2B are distinct from each other (16). Many synaptic components, such as AP-2, Ca^sup 2+^ channels, other copies of syt, and PIP^sub 2^ (phosphatidylinositol 4, 5-bisphosphate), interact with C2B but not with C2A (17-22).

Tethering of C2A and C2B equips syt with additional, novel, biochemical properties; namely, both C2-domains are required for syt to efficiently bind SNARE (soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor) proteins, which are components of a conserved membrane fusion machine (10,23-25). Cell-based and reconstitution experiments indicate that syt.SNARE interactions are essential for coupling Ca^sup 2+^ to SNARE-mediated membrane fusion (24,26-31). For example, it has been shown that altering the length of the linker that connects C2A and C2B reduces the interaction of syt with SNAREs and destabilizes exocytotic fusion pores in PC12 cells (30). These data demonstrate that the close physical coupling of the tandem C2-domains is critical for its function during secretion.

Cooperation between tethered C2A and C2B has also been reported for the Ca^sup 2+^-triggered interaction of syt with liposomes composed of PS and PC (phosphatidylcholine) (32). The functional relevance of the interaction of Ca^sup 2+^-syt with PS was addressed using a reconstituted, SNARE-mediated membrane fusion assay (24). Omission of PS from SNARE-bearing proteoliposomes completely abrogated the ability of Ca^sup 2+^.syt to regulate fusion in this assay system (31). Thus, PS is an essential effector for the action of Ca^sup 2+^.syt. In the context of the intact cytoplasmic domain of syt, C2A-C2B, two Ca^sup 2+^-binding loops of C2B rapidly penetrate PS-bearing lipid bilayers to form a high affinity complex (20,32). In contrast, studies focused on the isolated C2B domain have resulted in a less conclusive view. For example, only low levels of PS/PC binding were observed in some studies (14,28,32,33), whereas robust binding to membranes composed of PS/PC was reported in another study (34). These differences may be due to different experimental conditions and assays used to monitor binding (as detailed in Results).

The interlace between the C2-domains of syt and membranes contains positively charged residues that interact with the anionic headgroups of PS (12,13,20). These residues have been mutated and the effects of these mutations characterized at biochemical and functional levels (35,36). Mutation of one of the positively charged residues in either C2A (R233Q) or C2B (K366Q) shifted the Ca^sup 2+^ dependence of C2A-C2B-PS/PC membrane interactions: however, the R233Q/K366Q double mutant did not exhibit a further shift in the Ca"+ dependence for binding to PS-bearing liposomes (36); that is, a mutation in C2A seems to reduce the Ca^sup 2+^-dependent binding of C2B-domain to membranes, and this deficit could not be further exacerbated by an additional analogous mutation in C2B. These data suggest that the R233Q/K366Q mutations disrupt the ability of C2A and C2B to functionally interact or "cooperate" with one another. However, these results can also be explained by the possibility that C2A and C2B interact with membranes in a mutually exclusive manner, i.e., C2A and C2B do not penetrate PS/PC membranes at the same time. In this model, once one C2-domain penetrates into PS/PC bilayers, the other C2-domain is rendered unable to dip into lipid bilayers.

Here, using site-directed fluorescent probes, we report that C2A and C2B penetrate into lipid bilayers at the same time. Stopped-flow rapid mixing experiments show that both C2A and C2B, in the context of C2A-C2B, interact with PS/PC membranes with rapid and identical-within the lime resolution of the assay-kinetics. In addition, we address the question of whether the isolated C2B domain of syt functions as an efficient PS-binding module (34) or whether this domain must be activated by an adjacent C2A domain (32). The data presented here suggest that the tandem C2-domains of syt synergize in a complex manner to mediate high affinity binding of Ca^sup 2+^.syt to PS-harboring membranes.

MATERIALS AND METHODS

Recombinant proteins

cDNA encoding ml syl I (G374 version) (15,37) was kindly provided by G. Schiavo (Imperial Cancer Research Fund). The cytoplasmic (designated C2A-C2B, residues 96-421), C2A (residues 96-265), and C2B (residues 24X-421) domains of syl I (G374 version) were expressed in Esclierichia coli as glulalhione S-transferase fusion proteins and purified by using glutathione-Sepharose heads (Amersham Phamiacia, Piscalaway, NJ) as described (23,38). Recombinant syts harbor lightly bound contaminants that may affect their properties (14,33). These bacterial contaminants were removed using DNAase/RNAase and high salt washes as described previously (20). Soluble proleins were generated by thronibin cleavage of their respective GST fusion proleins. as described (38).

In C2A-C2B, the native Cys-277 was replaced with Ala, and a single Cys was introduced in loop 3 of C2A (F234C; designated C2A(3)-C2B), C2B (I367C; designated C2A-C2B(3)), or both C2-domains (designated C2A(3)-C2B(3)). A single Cys was also placed in loop 1 of the C2B domain of C2A-C2B (V304C; designated C2A-C2B(1)) and in loop 1 or loop 3 of the isolated C2B domain (indicated as C2B(1) and C2B(3), respectively). In C2A^sub M^-C2B(3) and C2A^sub M^-C2B, the subscript M corresponds to D-230, 232N substitutions that disrupt the Ca^sup 2+^ and lipid-binding activity of C2A (39). In C2A-C2B^sub M^ and C2A(3)-C2B^sub M^, the subscript M corresponds to D-363, 36SN substitutions that disrupt the Ca^sup 2+^ and lipid-binding activity of C2B (14). All point mutations were generated using the overlapping primer method as described (40).

In C2B(KK), C2A-C2B(KK), and C2A^sub M^-C2B(KK), KK corresponds to K-326, 327A substitutions that neutralize the two lysine residues previously shown to be crucial for the oligomerization activity of C2B (19,33).

cDNA encoding these constructs were subcloned into pGEX-2T (Amersham Pharmacia) using BamHI and EcoRI sites, expressed in E. coli, and purified as described above.

Fluorescent labeling of C2A-C2B

Cys residues in C2A-C2B were labeled by incubating purified protein with a 10-fold molar excess of 1,5-IAEDANS (5-[[2-[(iodoacetyl) amino] ethyl] amino] naphthalene-1-sulfonic acid) (Molecular Probes, Eugene, OR) at 25�C for 1 h in HEPES buffer (50 mM HEPES, pH 7.4, 0.1 M NaCl; the same buffer was used for all experiments unless otherwise indicated). Free lluorophore was removed by extensive dialysis. The AEDANS concentration was determined using an extinction coefficient of 6.0 � 10^sup 3^ M^sup -1^ cm^sup -1^ at 337 nm (32,41). The protein concentration was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and staining with Coomassie brilliant blue using bovine serum albumin as a standard. Labeling ratios were 0.85-0.95 mol label/mole of protein. AEDANS probes on proteins are represented as asterisks (*) in all figures.

Phospholipids

Synthetic 1.2-dioleoyl-sn-glycero-3-[phospho-L-serine] (PS), synthetic 1,2-dioleoyl-sn-glycero-3-phosphocholine (PC), 1-palmiloyl-2-slearoyl (5-doxyl)-sn-glycero-3-phosphocholine (5-doxyl-PC), 1-palmitoyl-2-stearoyl (7-doxyl)-sn-glycero-3-phosphocholine (7-doxyl-PC), and 1-palmitoyl-2-stearoyl (12-doxyl)-sn-glycero-3-phosphocholine (12-doxyl-PC), brain-derived PS, brainderived PC, and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(5-dimethylamino-1-naphthalenesulfonyl) (dansyl-PE) were oblained from Avanti Polar Lipids (Alabaster, AL).

Liposomes

Phospholipids were dried under a slivam of nitrogen and suspended in HEPES buffer. For fluorescence studies, large (~ 100 nm) unilamellar liposomes were prepared by extrusion as described previously (10).

Fluorescence measurements

Steady-stale fluorescence measurements were performed at 25�C using a PTI (South Brunswick, NJ) QM-1 fluorometer with FELIX software. Labeled protein (0.5 �M) was mixed with liposomes (11 nM liposomes or 1 mM total phospholipids) in a cuvette using a castle-style stir bar. AEDANS was excited at 336 nm, and emission spectra were collected from 420 to 600 nm (2-nm slits) and were corrected for blank, dilution, and instrument response. |Ca^sup 2+^]^sub free^ was calculated using WEBMAXC 2.22 software (C. Patton, Stanford University, Stanford, CA). For the quenching experiments shown in Supplementary Fig. 1, liposome composition was 25% PS, 65% PC, and 10% doxyl-PC; the doxyl group was placed at the 5-, 7-, or 12-position of the sn-2 acyl chain.

Cosedimentation assays

Large (~100 nm) unilamelkir liposomes were prepared using synthetic phospholipids (25% PS/75% PC). Syt fragments (3 �M) were incubated with liposomes (22 nM liposomes or 2 mM total phospholipids) in 100 �l of HEPES buffer for 15 min at room temperature, in the presence of 1 mM Ca^sup 2+^ or 2 mM EGTA. Samples were then centrifuged at 150,000 � g at 4�C for 40 min in a Beckman Optima MAX-E (Beckman Coulter, Fullerton, CA) tabletop ultracentrifuge, and the supernatants and pellets were collected. Pellets were washed once with 100 �l of HEPES buffer and collected again via centrifugation. Equal fractions of the supernatant and pellet from each sample were subjected to SDS-PAGE, and proteins were visualized by staining with Coomassie brilliant blue.

RESULTS

Site-directed probes have been used to gain insight into the mechanism and kinetics by which Ca^sup 2+^.syt engages membranes. These studies revealed that in response to Ca^sup 2+^, the Ca^sup 2+^-binding loops of both C2A and C2B, in the context of the intact cytoplasmic domain (designated C2A-C2B), penetrate membranes that contain anionic phospholipids (10,13, 20,32). Hovsever, it was not clear whether Ca^sup 2+^.C2A-membrane and Ca^sup 2+^.C2B-membrane interactions occur simultaneously, with distinct kinetics, or in a mutually exclusive manner.

To address these issues, we used a site-directed fluorescent probe. AEDANS, to label Ca^sup 2+^-binding loop 3 of C2A or C2B (indicated as C2A*(3)-C2B or C2A-C2B*(3), respectively, as shown in Fig. 1 A, upper panel). Results from steady-state fluorescence measurements using these constructs are consistent with previous studies (20,32). Both C2A*(3)-C2B and C2A-C2B*(3) exhibited a Ca^sup 2+^-dependent increase in fluorescence intensity and a blue-shift in the emission spectrum when mixed with liposomes that harbored the anionic phospholipid PS (25% PS/75% PC) (Fig. 1, A and B, lower panel). These changes in the emission spectrum report the Ca^sup 2+^-triggered penetration of the Ca^sup 2+^-binding loops of C2A and C2B into the lipid bilayer (20). Moreover, we generated a double-labeled Cys mutant-C2A*(3)-C2B*(3)-in which loop 3 of both C2A and C2B are labeled (Fig. 1 C, upper panel). If both C2A and C2B insert into PS/PC membranes, the fluorescence change in C2A*(3)-C2B*(3) would be the sum of the changes exhibited by C2A*(3)-C2B and C2A-C2B*(3). As shown in Fig. 1 C (lower panel), this was in fact the case-the fluorescence changes exhibited by the double-labeled mutant corresponded to the sum of the signals from the individually labeled C2-domains. The solid lines, which were obtained from fluorescence measurements of C2A*(3)-C2B*(3), agree very well with the corresponding dashed lines that were calculated by summing the spectra of the two single (C2A*(3)-C2B and C2A-C2B*(3)) labeled proteins. The additive Ca^sup 2+^/liposome-induced changes in the fluorescence signals from C2A and C2B are consistent with a model in which the tandem C2-domains of syt copcnetrate into the hydrophobic core of lipid bilayers.

The findings described above could also be explained by another model: the C2A and C2B penetrate into the lipid bilayer in an equal, yet mutually exclusive, manner. For example, we consider the possibility that, among a population of C2A-C2B molecules, only C2A interacts with membranes in half the population whereas only C2B interacts with membranes in the other half of the population at any given time (Fig. 2 A, lower panel). In this case, the fluorescence change of each singly labeled C2A-C2B corresponds to penetration of only half of the C2A-C2B molecules into the bilayer. Thus, the fluorescence increase of double-labeled C2A-C2B would also be ~2-fold. This possibility was ruled out by comparing the fluorescence spectra of C2A*(3)-C2B and C2A*(3)-C2B^sub M^; this latter construct is a mutant in which the membrane penetration activity within C2B has been completely disrupted (14). This construct was selected for two reasons: first. C2A has been shown to penetrate membranes with a nanomolar aftinity (k^sub on^ [much greater than] k^sub off^) (10) and efficiently cosediments with liposomes under conditions similar to the fluorescence measurements reported here (please refer to Fig. 5 A). These data indicate that most, if not all, of the C2A-C2B^sub M^ molecules absorb onto liposomes in response to Ca^sup 2+^. Second, the mutant C2B domain of C2A*(3)-C2B^sub M^ does not penetrate membranes and thus is unable to compete with C2A. Hence, in C2A*(3)-C2BM, virtually all of the Ca^sup 2+^/membrane-binding loops of C2A are expected to be buried into the membrane (Fig. 2 B, lower panel). If the membrane penetration activity of C2A and C2B are mutually exclusive (that is, they "compete" with each other for insertion into bilayers), we would expect to see a larger fluorescence change (upon inserting into bilayers) in C2A*(3)-C2B^sub M^ than in C2A*(3)-C2B. However, disruption of the membrane penetration activity of C2B tailed to increase the penetration of C2A, demonstrating that C2A and C2B, within the cytoplasmic domain of syt, do not penetrate membranes in a mutually exclusive manner. We conclude that C2A and C2B copenetrate membranes.

As alluded to above, the spectral changes observed in Figs. 1 and 2 have been previously shown, using membrane-embedded quenchers and the parallax method, to be due to direct penetration of the AEDANS reporter (on loop 3) into the hydrophobic core of lipid bilayers (32). We have extended these experiments to include AEDANS probes on loop 1 of C2A or C2B and found that these Ca^sup 2+^-binding loops penetrate membrane in a manner analogous to loop 3 (~1/5th into the hydrophobic core of the PS/PC bilayer; Supplementary Fig. 1). These experiments confirm that Ca^sup 2+^-binding loops 1 and 3, in both C2-domains, penetrate PS/PC membranes in response to Ca^sup 2+^.

We next determined whether C2A and C2B penetrate membranes simultaneously or with distinct kinetics, using a stopped-flow rapid mixing approach. Rapid mixing of liposomes and Ca^sup 2+^ with C2A*(3)-C2B, C2A-C2B*(3), or C2A*(3)-C2B*(3) resulted in rapid changes in all three fluorescence signals (Fig. 3 A). The raw data traces were well titled with single exponential functions. Using 11 nM liposomes (100 nm in diameter), the observed rates (k^sub obs^) were 228 s^sup -1^, 230 s^sup -1^, and 205 s^sup -1^ for C2A*(3)-C2B, C2A-C2B* (3) and C2A*(3)-C2B*(3). respectively. We then measured k^sub obs^ as a function of [liposome] and calculated the on-rate (k^sub on^), off-rate (k^sub off^), and the dissociation constants (K^sub d^) for labeled C2A-C2B-liposome interactions as described in Fig. 3 D; these data are summarized in Fig. 3 E. Consistent with previous reports using brain-derived phospholipids (32), the on-rates for C2A*(3)-C2B and C2A-C2B*(3) penetration are almost identical and both approach the diffusion limit. Moreover, the fluorescence changes for double-labeled C2A*(3)-C2B*(3) were also well fitted by single exponential functions, further supporting the idea that C2A and C2B copenetrate membranes simultaneously, or at least within the uncertainty of the kinetics measurements. We note that the double-labeled protein, C2A*(3)-C2B*(3) exhibited a slightly lower on-rate and a slightly higher off-rate than the mutants with only a single label. These subtle changes could be due to the AEDANS label, which is a bulky molecule (~12 [Angstrom]) that carries a negative charge. However, parallel experiments using FRET to monitor protein-lipid interactions (using wild-type C2A-C2B lacking a label) revealed that the AEDANS probe had little, if any, effect on the kinetics of C2A-C2B-membrane interactions (Fig. 6 B compared to Fig. 3 E).

In the next series of experiments, we sought to shed light on the debate regarding the ability of isolated C2B to interact with PS-bearing membranes (20,32,34). Although it is well established that C2B interacts with PS/PC membranes in the context of C2A-C2B, it is unclear whether the isolated C2B domain binds PS-containing membranes with high affinity. In some studies, low or trace levels of binding were reported (14,20,32,33). However, in another study it was reported that isolated C2B penetrated PS/PC membranes as well as C2A (34).

To address this apparent contradiction, we explored the stability of the putative membrane penetration activity of isolated C2B using the AEDANS probes described above. The degree of penetration was assayed as a function of ionic strength. Ca^sup 2+^/liposome-dependent fluorescence changes of the AEDANS probe in isolated C2B*(3), C2A-C2B*(3), and C2A^sub M^-C2B*(3) were compared (Fig. 4). We found that isolated C2B*(3) exhibited only low levels of membrane penetration activity in the presence of 100 mM NaCl. However, this interaction was extremely sensitive to ionic strength, as evidenced by the sharp decrease in the degree of penetration as the [NaCl] was increased to physiological concentrations (Fig. 4 D).

In these experiments, the membrane penetration activity of loop 3 of isolated C2B was abolished by 150 mM NaCl. However, an adjacent C2A domain strongly enhanced the membrane penetration activity of C2B (Fig. 4 B). This penetration activity was not dependent on the Ca^sup 2+^-binding ability of C2A, since C2B could also be activated by a "dead" C2A domain (designated C2A^sub M^; Fig. 4 C) that does not hind membranes or Ca^sup 2+^ (32). A significant degree of membrane penetration of loop 3 of C2B, in the context of C2A^sub M^-C2B, persisted at very high salt concentrations, indicating that this is a highly stable interaction (Fig. 4 D). These data agree with our previous model in which C2A activates an otherwise hidden or cryptic membrane penetration activity within the adjacent C2B domain.

Changes in ionic strength can affect the emission spectra of a number of fluorophores. In this study, increasing the ionic strength caused only a minor decrease in the fluorescence intensity of AEDANS-labeled C2A-C2B free in solution (Supplementary Fig. 2). Therefore, the marked decrease in fluorescence intensity that we observed in Fig. 4 D is mainly due to loss of membrane penetration activity.

Brain-derived phospholipids were used in our previous studies in which isolated C2B failed to penetrate membranes (32), whereas synthetic phospholipids were used by Rufener et al. (34) who reported efficient membrane penetration activity of isolated C2B. Here, both types of phospholipids were used and compared. The level of C2B*(3) penetration was somewhat greater using synthetic phospholipids. but this did not change the overall trend in these experiments, further supporting a model in which C2A activates a cryptic membrane penetration activity within C2B (32). It is not clear why native and synthetic lipids yield somewhat different results. Possible reasons include differences in acyl chain packing and bilayer fluidity. Alternatively, these differences might rise from oxidative damage of the natural lipids. owing to the instability of polyunsaturated acyl chains or from the presence of impurities that quench the fluorophore or alter the properties of the bilayer.

For comparison, AEDANS was also used to explore the penetration activity of loop 1 of C2B, both in the context of isolated C2B (Supplementary Fig. 3 B) and in the intact cytoplasmic domain of syt, C2A-C2B (Supplementary Fig. 1 C). In isolated C2B, loop 1 was able to penetrate membranes to some degree at physiological salt concentrations. This activity was weaker than the positive control, isolated C2A. but was stronger than the penetration activity of loop 3 of C2B (Supplementary Fig. 3, A and D). The interaction between loop 1 of C2B and PS/PC membranes was readily disrupted by increasing the ionic strength, especially when the liposomes were generated from brain-derived phospholipids (Supplementary Fig. 3, B and D). Again, the stability was greatly enhanced by an adjacent C2A domain (Supplementary Fig. 3, C and D).

Direct comparison between the penetration of C2A-C2B*(1) and C2A-C2B*(3) revealed some interesting differences. In the context of C2A-C2B, at low salt concentrations, loop 3 of C2B penetrated more efficiently into the membrane than loop 1 (Fig. 4 D compared to Supplementary Fig. 3 D). However, the penetration of loop I was more stable, as evidenced by its greater resistance to increasing ionic strength. These results suggest that the two Ca^sup 2+^-binding loops within the C2B domain are not equal. In light of these findings, we compared the penetration kinetics of loops 1 and 3 of C2B, again in the context of C2A-C2B, using a stopped-flow rapid mixing approach. Labels in either loop of C2B reported similar penetration kinetics (Supplementary Fig. 3, E-G). The observed rate constant for C2A-C2B* (1) was only slightly less than that of C2A-C2B* (3). It is likely that in response to Ca^sup 2+^, both loops of C2B rapidly clip into the membrane. However, the interaction of loop 1 with PS/PC membranes seems to be stronger or at least less dependent on electrostatic interactions than that of loop 3. This latter possibility is supported by the presence of two lysine residues (K-366 and K-369) within loop 3 of C2B and the absence of charged residues in loop 1 of C2B.

To further characterize the effects of ionic strength on the interaction of syt with liposomes, we carried out C2A-C2B-liposomecosedimentation assays. Cosedimentation, using isolated or tethered C2-domains, was monitored us a function of ionic strength (Fig. 5 A). In all cases, cosedimentation was sensitive to ionic strength, consistent with previous reports (36,40). The positive control, wild-type C2A-C2B, exhibited the greatest salt resistance, whereas the isolated C2B domain was readily stripped from liposomes by increasing the ionic strength. However, when a mutant C2A (C2A^sub M^) domain that fails to hind Ca^sup 2+^' or PS (32) was tethered to C2B, resistance to increasing ionic strength was greatly enhanced, indicating a significant increase in the strength and/or stability of the protein-membrane complexes. In addition, experiments utilizing isolated C2-domains revealed that Ca^sup 2+^-C2A-membrane complexes were much more resistant to high salt than Ca^sup 2+^-C2B-membrane complexes. C2A.membrane interactions were also slightly enhanced by an adjacent mutant C2B domain (C2B^sub M^) that fails to bind Ca^sup 2+^ or PS, but this enhancement was much weaker than that of C2A^sub M^ on C2B. In terms of binding PS, C2A has a more significant effect on C2B than vice versa.

Since sedimentation involves both the membrane binding and oligomerization activity of syt fragments (33), the differences described above could be due to differences in either, or both, of these interactions. Therefore, we generated and purified K-326, 327A (designated KK) mutant versions of the syt fragments, which have been shown to lack oligomerization activity but have normal PS-binding activity (33). In 100 mM NaCl, the KK mutation reduced the sedimentation activity of C2B by ~60%; the remaining sedimentation is likely to represent the contribution from the relatively weak membrane-binding activity of C2B. This residual sedimentation activity was largely abolished when the salt concentration was increased to physiological levels (Fig. 5, C and D). These findings further indicate that the isolated C2B domain of syt does not avidly bind to PS (33). The presence of an adjacent C2A markedly enhanced the membrane-binding activity of C2B. Notably, this enhancement is not due to the ability of C2A to bind membranes and thereby "drag" the adjacent C2B domain onto membranes, since a "dead" C2A (C2A^sub M^) also enhanced the interaction to a significant extent. These results again confirm that C2A affects the properties of C2B.

The inability of isolated C2B to avidly interact with PS/PC membranes could be due to the presence of an N-terminal sequence that is not actually part of the structure of C2B. Structural data indicate that C2B actually begins at or near residue 271 (14,45). The experiments reported in this study made use of a construct that began at residue 248 because this longer construct is more readily purified in a soluble form. We compared the properties of the larger C2B construct (residues 248-421) with the shortest possible construct that did not contain any additional flanking residues (residues 271-421). These two versions of C2B exhibited identical abilities to cosediment with PS/PC liposomes as a function of increasing ionic strength (Supplementary Fig. 4). These data indicate that the longer C2B construct is not self-inhibited by the presence of extra residues at the N-terminus.

In all of the experiments reported in this study, "clean" fragments of syt, in which all bacterial contaminants had been removed (14,33), were used. We have also characterized "dirty" C2B that carries the bacterial contaminants (which are RNA and/or DNA) and found no significant differences in the fluorescence and cosedimentation experiments (E. Hui and E. R. Chapman, unpublished observations).

The kinetics of Ca^sup 2+^-triggered membrane penetration of C2A has been studied in detail (10), but little is known concerning the kinetics of C2B. In the final series of experiments we measured the kinetics of C2B-membrane interactions. Since isolated C2B exhibits little PS-binding activity, we carried out these experiments using C2A^sub M^-C2B. In this construct, C2A^sub M^ cannot bind Ca^sup 2+^ or PS but can enhance the PS penetration activity of the adjacent C2B domain (Fig. 4 D and Bai et al. (32)), making it possible to measure the kinetics of Ca^sup 2+^-C2B-PS interactions. For these experiments we monitored protein-liposome complex formation using FRET from the native tryptophan residues in C2A^sub M^-C2B to a dansyl-acceptor (attached to the headgroup of phosphatidylethanolamine (PE)) on the liposomes. Stopped-flow rapid mixing experiments were carried out as a function of [liposome] as described in Fig. 3. These experiments indicate that C2Bmediated interactions with PS/PC liposomes occur on rapid timescales and approach the collision limit for complex assembly (Fig. 6, A and B). Like C2A, C2B rapidly senses Ca^sup 2+^ and binds to membranes, readily fulfilling the kinetic constraints of rapid exocytosis.

DISCUSSION

Initial biochemical studies of syt revealed that this synaptic vesicle protein binds to PS-bearing membranes in response to Ca^sup 2+^ (46). These results suggested that syt might function as a Ca^sup 2+^ sensor during neuronal exocytosis. and this idea was confirmed in numerous biochemical, genetic, and biophysical experiments (4-6,24). However, the molecular mechanism by which Ca^sup 2+^ and syt regulate membrane fusion is not yet understood. It was recently shown that PS is an essential effector for the action of Ca^sup 2+^-syt in the regulation of SNARE-catalyzed membrane fusion that had been reconstituted in vitro (26,31). Hence, the mechanism by which Ca^sup 2+^-syt engages anionic phospholipids is critical for our understanding of the mechanism of regulated membrane fusion. Previous studies demonstrated that upon binding Ca^sup 2+^, the C2-domains of the cytoplasmic domain of syt (C2A-C2B) partially penetrate into PS/PC membranes. However, it was not clear whether C2A and C2B penetrate bilayers simultaneously or whether the tandem C2-domains penetrate into membranes in a mutually exclusive manner.

Combining site-directed fluorescent probes and a stopped-flow rapid mixing approach, we found that in response to Ca^sup 2+^, the Ca^sup 2+^-binding loops of both C2A and C2B simultaneously dip into PS/PC bilayers with rapid and apparently identical kinetics. These experiments demonstrate that when Ca^sup 2+^-syt engages PS, Ca^sup 2+^-binding loops of both C2-domains simultaneously insert into the PS-harboring membrane. However, disruption of the Ca^sup 2+^ and PS-binding activity of either C2A or C2B had surprisingly mild effects on the dissociation constant (K^sub d^) or off-rate of C2A-C2B.liposome complexes (Fig. 6 B). It has been shown that, in some cases, tethering two independent domains together can greatly enhance the overall affinity of binding between macromolecules since binding of one domain increases the local concentration of the other and vice versa (47). Disruption of the Ca^sup 2+^- and membrane-binding activity of either C2-domain of syt would eliminate this enhancement and give rise to significant effects on the off-rate and K^sub d^ for syt-membrane interactions. These changes, however, were not observed in our study (Fig. 6 B). Thus, a likely explanation for these results is that C2A and C2B synergize in a complex manner to bind to membranes and are not completely autonomous domains connected by a linker.

The complexity of the synergistic relationship between C2A and C2B is further illustrated by comparisons between the PS-binding properties of the isolated C2-domains of syt. In this study, cosedimentation assays and fluorescent probes were applied to examine C2B.membrane interactions under various conditions. In both assays, the interaction between the C2B domain of syt and membranes composed of PS/PC was generally much weaker and less resistant to salt when compared to C2A and C2A-C2B. When C2B was tethered to C2A^sub M^, which is a mutant version of C2A that is unable to bind Ca^sup 2+^ or PS/PC membranes (as demonstrated in Bai et al. (32)), the stability of the protein-membrane complex was markedly enhanced. These data confirm that a novel form of synergy or cooperativity between C2A and C2B (rather than the Ca^sup 2+^-dependent membrane-binding activity of C2A) converts the C2B domain into a high affinity membrane-binding module (32). In addition, two Ca^sup 2+^-binding loops of C2B also exhibit different abilities to penetrate into PS/PC bilaycrs; i.e., in response to Ca^sup 2+^, Ca^sup 2+^-binding loop 1, but not loop 3, dips into PS/PC membranes even in buffers with relatively high ionic strength. This may be due to the fact that there are two lysine residues located in loop 1 but only neutral residues are present in loop 3. However, the overall interaction of unlabeled isolated C2B with PS/PC liposomes is more sensitive to ionic strength than isolated C2A, C2A^sub M^-C2B, and C2A-C2B in the cosedimentation assay (Fig. 5). According to this assay, Ca^sup 2+^-C2B-PS/PC interactions are relatively weak, as C2B can be readily stripped from PS/PC vesicles at moderate ionic strength.

The data reported here highlight the idea that the properties of the C2B domain of syt can be profoundly influenced by the adjacent C2A domain. Our data also reveal that some of the uncertainty regarding the interaction of isolated C2B with PS/PC membranes can be largely attributed to differences in ionic strength of the buffers, the use of different kinds of binding assays (e.g., FRET/stopped-llow, fluorescent probe penetration, cosedimentation, etc.), and differences in materials (e.g., synthetic versus natural phospholipids). In particular, Rutener et al. reported that isolated C2A and C2B bind PS/PC membranes with a similar affinity and that isolated C2B dips into PS/PC bilayers in a manner that is very similar to C2A (34). However, in their study, the affinity of the C2B-mEmbrane interaction was measured using Tb^sup 3+^ and not Ca^sup 2+^.

We have found that Ca^sup 2+^ is unable to effectively compete with Tb^sup 3+^ for binding to C2-domains (L. F. Davis and E. R. Chapman, unpublished observations). Thus, Tb^sup 3+^ might not mimic the effects of Ca^sup 2+^ in terms of activating syt-membrane interactions. For membrane dipping, electron spin resonance experiments were carried out using high concentrations of protein and lipiD (20-300 �M isolated C2B and 40-60 mM lipids) as compared to our fluorescence assays (0.5 �M C2B and 1 mM total lipids). High concentrations of protein would favor binding despite the low affinity of Ca^sup 2+^-C2B-membrane complexes. Finally, Rufener et al. used synthetic, rather than natural, phospholipids. As we show in this study, isolated C2B is more likely to penetrate membranes made with synthetic phospholipids. The emerging view is that isolated C2B binds to PS/PC membranes much more weakly than C2A, but under some conditions, isolated C2B can partially penetrate into PS/PC bilayers.

The main finding reported here is that in the intact cytoplasmic domain of syt, C2A and C2B rapidly copenetrate into PS/PC bilayers; both Ca^sup 2+^-binding loops 1 and 3, in both C2-domains, penetrate into the hydrophobic core of membranes. Hence, a detailed view of the dynamics of Ca^sup 2+^.syt-membrane interactions, and the structure of this complex, has emerged (10,12,13,20,32,34,48). The interaction of syt with lipid bilayers can drive the close apposition of membranes (49,50) to potentially facilitate membrane fusion (20,31,46). Also, it was recently shown that the interaction of syt with PS facilitates the assembly of SNARE complexes, which may also serve to trigger membrane fusion (26).

A number of studies indicate that both C2-domains of syt play roles in the regulation of exocytosis and membrane fusion (e.g., 21,24,31,35,36,51-54). The precise mechanisms by which syt regulates secretion will be further revealed by addressing the immediate consequences of Ca^sup 2+^ binding to its tandem C2-domains. New insights will be gained by studying the behavior of single molecules, by increasing the time resolution of dynamic measurements, and by studying rearrangements between syt and its effectors in living cells.

SUPPLEMENTARY MATERIAL

An online supplement to this article can be found by visiting BJ Online at http://www.biophysj.org.

We thank Meyer Jackson and momhers of the Chapman lab for discussions and comments.

This study was supported by grants from the National Institutes of Health (NIGMS GM 56827 and NIMH MH61876) and the American Heart Association (0440168N) to E.R.C., E.R.C. is an Investigator of the Howard Hughes Medical Institute.

[Reference]

REFERENCES

1. Katz, B. 1969. The Release of Neural Transmitter Substances. Thomas, Springfield, IL.

2. Meinrenken, C. J., J. G. Borst, and B. Sakmann. 2003. Local routes revisited: the space and lime dependence of the Ca^sup 2+^ signal for phasic transmitter release at the rat calyx of Held. J. Physiol. 547:665-689.

3. Schneggenhurger, R., and E. Neher. 2005. Presynaptic calcium and control of vesicle fusion. Curr. Opin. Neurobiol. 15:266-274.

4. Augustine, G. J. 2001. How does calcium trigger neurotransmitter release? Curr. Opin. Neurobiol. 11:320-326.

5. Koh, T. W., and H. J. Bellen. 2003. Synaptotagmin I, a Ca^sup 2+^ sensor for neurotransmitter release. Trends Neurosci. 26:413-422.

6. Chapman, E. R. 2002. Synaptolagmin: a Ca^sup 2+^ sensor that triggers exocytosis? Nat. Rev. Mol. Cell Biol. 3:498-508.

7. Perin, M. S., V. A. Fried, G. A. Mignery, R. Jahn, and T. C. Sudhof. 1990. Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C. Nature. 345:260-263.

8. Perin, M. S., N. Brose, R. Jahn, and T. C. Sudhof. 1991. Domain structure of synaptotagmin (p65). J. Biol. Chem. 266:623-629.

9. Davletov, B. A., and T. C. Sudhof. 1993. A single C2 domain from synaptotagmin I is sufficient for high affinity Ca^sup 2+^/phospholipid binding. J. Biol. Chem. 268:26386-26390.

10. Davis, A. F., J. Bai, D. Fasshauer, M. J. Wolowick, J. L. Lewis, and E. R. Chapman. 1999. Kinetics of synaplotagmin responses to Ca^sup 2+^ and assembly with the core SNARE complex onto membranes. Neuron. 24:363-376.

11. Sutton, R. B., B. A. Davletov, A. M. Berghuis, T. C. Sudhof, and S. R. Sprang. 1995. Structure of the first C2 domain of synaplotagmin I: a novel Ca^sup 2+^/phospholipid-binding fold. Cell. 80:929-938.

12. Chapman, E. R., and A. F. Davis. 1998. Direct interaction of a Ca^sup 2+^-binding loop of synaptotagmin with lipid bilayers. J. Biol. Chem. 273:13995-14001.

13. Bai, J., C. A. Earles, J. L. Lewis, and E. R. Chapman. 2000. Membrane-embedded synaptotagmin penetrates cis or trans target membranes and clusters via a novel mechanism. J. Biol. Chem. 275:25427-25435.

14. Fernandez, I., D. Arac, J. Ubach, S. H. Gerber, O. Shin, V. Gao, R. G. Anderson, T. C. Sudhof, and J. Rizo. 2001. Three-dimensional structure of the synaptotagmin 1 C2B-domain. Synaptotagmin 1 as a phospholipid binding machine. Neuron. 32:1057-1069.

15. Desai, R. C., B. Vyas, C. A. Earles, J. T. Littleton, J. A. Kowalchyck. T. F. Martin, and E. R. Chapman. 2000. The C2B domain of synaptotagmin is a Ca^sup 2+^-sensing module essential for exocylosis. J. Cell Biol. 150:1125-1136.

16. Tucker, W. C., and E. R. Chapman. 2002. Role of synaptotagmin in Ca^sup 2+^-triggered exocytosis. Biochem. J. 366:1-1.3.

17. Zhang, J. Z., B. A. Davlelov, T. C. Sudhof, and R. G. Anderson. 1994. Synaptolagmin I is a high affinity receptor for clathrin AP-2: implications for membrane recycling. Cell. 78:751-760.

18. Shong, J. H., C. T. Yokoyama, and W. A. Catlerall. 1997. Interaction of the synprint site of N-type Ca^sup 2+^ channels with the C2B domain of synaplotagmin I. Proc. Natl. Acad. Sci. USA. 94:5405-5410.

19. Chapman, E. R., R. C. Desai, A. F. Davis, and C. K. Tornehl. 1998. Delineation of the oligomerization, AP-2 binding, and synprint binding region of the C2B domain of synaptotagmin. J. Biol. Chem. 273:32966-32972.

20. Bai, J., W. C. Tucker, and H. R. Chapman. 2004. PIP^sub 2^ increases the speed-of-response of synaptotagmin and steers its membrane penetration activity toward the plasma membrane. Nat. Struct. Mol. Biol. 11:36-44.

21. Littleton, J. T., J. Bai, B. Vyas, R. Desai, A. E. Baltus, M. B. Garment, S. D. Carlson, B. Ganetzky, and E. R. Chapman. 2001. Synaptotagmin mutants reveal essential functions for the C2B domain in Ca^sup 2+^-triggered fusion and recycling of synaptic vesicles in vivo. J. Neurosci. 21:1421-1433.

22. Schiavo, G., Q. M. Gu, G. D. Prestwich, T. H. Sollner, and J. E. Rothman. 1996. Calcium-dependent switching of the specificity of phosphoinositide binding to synaplotagmin. Proc. Natl. Acad. Sci. USA. 93:13327-13332.

23. Chapman, E. R., S. An, J. M. Edwardson, and R. Jahn. 1996. A novel function for the second C2 domain of synaptotagmin. Ca^sup 2+^-triggered dimerization. J. Biol. Chem. 271:5844-5849.

24. Tucker, W. C., T. Weber, and E. R. Chapman. 2004. Reconstitution of Ca^sup 2+^-regulated membrane fusion by synaptotagmin and SNAREs. Science. 304:435-438.

25. Tucker, W. C., J. M. Edwardson, J. Bai, H. J. Kim, T. F. Martin, and E. R. Chapman. 2003. Identification of synaptotagmin effectors via acute inhibition of secretion from cracked PC12 cells. J. Cell Biol. 162:199-209.

26. Bhalla, A., M. C. Chicka, W. C. Tucker, and E. R. Chapman. 2006. Ca(^sup 2+^)-synaplotagmin directly regulates t-SNARE function during reconstituted membrane fusion. Natl. Struct. Mol. Biol.

27. Lu, X., Y. Xu, F. Zhang, and Y. K. Shin. 2006. Synaplotagmin I and Ca(^sup 2+^) promote half fusion more than full fusion in SNARE-mediated bilayer fusion. FEBS Lett. 580:2238-2246.

28. Earles, C. A., J. Bai, P. Wang, and E. R. Chapman. 2001. The tandem C2 domains of synaptolagmin contain redundant Ca^sup 2+^ binding sites that cooperate to engage t-SNAREs and trigger exocytosis. J. Cell Biol. 154:1117-1123.

29. Zhang, X., M. J. Kim-Miller, M. Fukuda, J. A. Kowalchyk, and T. F. Martin. 2002. Ca^sup 2+^-dependent synaptolagmin binding to SNAP-25 is essential for Ca^sup 2+^-triggered exocylosis. Neuron. 34:599-611.

30. Bai, J., C. T. Wang, D. A. Richards, M. B. Jackson, and E. R. Chapman. 2004. Fusion pore dynamics are regulated by synaplotagmin*t-SNARE interactions. Neuron. 41:929-942.

31. Bhalla, A., W. C. Tucker, and E. R. Chapman. 2005. Synaptotagmin isoforms couple distinct ranges of Ca^sup 2+^, Ba^sup 2+^, and Sr^sup 2+^ concentration to SNARE-mediated membrane fusion. Mol. Biol. Cell. 16:4755-4764.

32. Bai, J., P. Wang, and E. R. Chapman. 2002. C2A activates a cryptic Ca^sup 2+^-triggered membrane penetration activity within the C2B domain of synapmtagmin I. Proc. Natl. Acad. Sci. USA. 99:1665-1670.

33. Wu, Y., Y. He, J. Bai, S. R. Ji, W. C. Tucker, E. R. Chapman, and S. F. Sui. 2003. Visualization of synaptolagmin I oligomers assembled onto lipid monolayers. Proc. Natl. Acad. Sci. USA. 100:2082-20X7.

34. Rufener, E., A. A. Frazier, C. M. Wieser, A. Hinderliter, and D. S. Cafiso. 2005. Membrane-bound orientation and position of the synapioiagmin C2B domain determined by site-directed spin labeling. Biochemistry: 44:18-28.

35. Feniandez-Chacon, R., A. Konigstorfer, S. H. Gerber, J. Garcia, M. F. Matos, C. F. Stevens, N. Brose, J. Rizo, C. Rosenmund, and T. C. Sudhol. 2001. Synaptotagmin I functions as a calcium regulator of release probability. Nature. 410:41-49.

36. Wang, P., C. T. Wang, J. Bai, M. B. Jackson, and E. R. Chapman. 2003. Mutations in the effector binding loops in the C2A and C2B domains of synaptotagmin I disrupt exocytosis in a non-additive manner. J. Biol. Chem. 278:47030-47037.

37. Oshorne, S. L., J. Herreros, P. I. Bastiaens, and G. Schiavo. 1999. Calcium-dependent oligomerization of synaplotagmins I and II. Synaptotagmins I and II are localized on the same synaptic vesicle and helerodimerize in the presence of calcium. J. Biol Chem. 274:59-66.

38. Chapman, E. R., P. I. Hanson, S. An, and R. Jahn. 1995. Ca^sup 2+^ regulates the interaction between synaptolagmin and syntaxin 1. J. Biol. Chem. 270:23667-23671.

39. Zhang, X., J. Rizo, and T. C. Sudhof. 1998. Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I. Biochemistry. 37:12395-12403.

40. Chapman, E. R., and R. Jahn. 1994. Calcium-dependent interaction of the cytoplasmic region of synaptolagmin with membranes. Autonomous function of a single C2-homologous domain. J. Biol. Chem. 269:5735-5741.

41. Hudson, E. N., and G. Weber. 1973. Synthesis and characlerization of two fluorescent sulfhydryl reagents. Biochemistry. 12:4154-4161.

42. Ahrams, F. S., A. Chattopadhyay, and E. London. 1992. Determination of the location of fluorescent probes attached to fatly acids using parallax analysis of fluorescence quenching: effect of carhoxyl ionization state and environment on depth. Biochemistry. 31:5322-5327.

43. Chung, L. A., J. D. Lear, and W. F. DeOrado. 1992. Fluorescence studies of the secondary structure and orientation of a model ion channel peptide in phospholipid vesicles. Biochemistry. 31:6608-6616.

44. McIntosh, T. J., and P. W. Holloway. 1987. Determination of the depth of bromine atoms in bilayers formed from bromolipid probes. Biochemistry. 26:1783-1788.

45. Sutton, R. B., J. A. Ernst, and A, T. Brunger. 1999. Crystal structure of the cytosolic C2A-C2B domains of synaptolagmin III. Implications for Ca^sup 2+^-independent SNARE complex interaction. J. Cell Biol. 147:589-598.

46. Brose, N., A. G. Petrenko, T. C. Sudhof, and R. Jahn. 1992. Synaptolagmin: a calcium sensor on the synaptic vesicle surface. Science. 256:1021-1025.

47. Zhou, H. X. 2003. Quantitative account of the enhanced affinity of two linked scFvs specific for different epitopes on the same antigen. J. Mol. Biol. 329:1-8.

48. Frazer, A. A.,C. R. Roller,J. J. Havelka,A. Hinderliter,and D. S. Cafso. 2003. Membrane-bound orientation and position of the synaptotagmin I C2A domain by site-directed spin labeling. Biochemistry. 42:96-105.

49. Damer, C. K., and C. E. Creutz. 1994. Synergistic membrane interactions of the two C2 domains of synaptolagmin. J. Biol. Chem. 269:31115-31123.

50. Damer, C. K., and C. E. Creutz. 1996. Calcium-dependent self-association of synaptolagmin I. J. Neurochem. 67:1661-1668.

51. Mackler, J. M., J. A. Drummond, C. A. Loewen, I. M. Robinson, and N. E. Reist. 2002. The C2B Ca^sup 2+^-binding motif of synaptotagmin is required for synaptic transmission in vivo. Nature. 418:340-344.

52. Stevens, C. F., and J. M. Sullivan. 2003. The synaptolagmin C2A domain is part of the calcium sensor controlling fast synaptic transmission. Neuron. 39:299-308.

53. Nishiki, T., and G. J. Augustine. 2004. Dual roles of the C2B domain of synaptotagmin I in synchmnizing Ca^sup 2+^-dependent neurotransmitter release. J. Neurosci. 24:8542-8550.

54. Rhee, J. S., L. Y. Li, O. H. Shin, J. C. Rah, J. Rizo, T. C. Sudhof, and C. Rosenmund. 2005. Augmenting neurotransmitter release by enhancing the apparent Ca^sup 2+^ affinity of synaptolagmin 1. Proc. Natl. Acad. Sci. USA. 102:18664-18669.

[Author Affiliation]

Enfu Hui, Jihong Bai, and Edwin R. Chapman

Howard Hughes Medical Institute and Department of Physiology, University of Wisconsin School of Medicine, Madison, Wisconsin 53706

[Author Affiliation]

Submitted December 22, 2005, and accepted for publication June 1, 2006.

Address reprint requests to Edwin R. Chapman, HHMI and Dept. of Physiology, SMI 129, University of Wisconsin, 1300 University Ave., Madison, WI 53706. Tel.: 608-263-1762; Fax: 608-265-5512; E-mail: chapman@physiology.wisc.edu.

Jihong Bai's present address is Massachusetts General Hospital, Dept. of Molecular Biology, Richard B. Simches Research Building, 185 Cambridge St., CPZN-7250, Boston, MA 02114-2790.

Mukasey Favors Independent Justice Dept.

WASHINGTON - Lobbying for the job of the nation's top law enforcement officer, Attorney General-designate Michael Mukasey pledges to strike a delicate balance between keeping the nation safe and protecting the civil liberties of Americans.

"Protecting civil liberties, and people's confidence that those liberties are protected, is a part of protecting national security, just as is the gathering of intelligence to defend us from those who believe it is their duty to make war on us," Mukasey said in remarks prepared for delivery at his confirmation hearing, which began Wednesday morning. "We have to succeed at both."

His remarks, obtained by The Associated Press, were reassuring to Democrats seeking an attorney general comfortable with saying "no," if need be, to the president who nominated him. But Mukasey was facing tough questions, too, about whether he could set the leaderless Justice Department back on its feet after a season of scandal under former Attorney General Alberto Gonzales.

"This is a job interview for a big job that has become even bigger," Senate Judiciary Committee Chairman Patrick Leahy, D-Vt., said in his prepared remarks.

"The most important qualities we need in an Attorney General right now are independence and integrity, and Judge Mukasey seems to possess these vital attributes," said Sen. Charles Schumer, D-N.Y., in his prepared statement.

Both Democrats, along with Majority Leader Harry Reid, have predicted Mukasey will win quick confirmation after the panel's hearings this week.

Nonetheless, Mukasey was facing questions aimed at eliciting firm pledges of independence from the Bush White House, particularly on techniques for interrogating terrorism suspects and the president's controversial eavesdropping program. In private meetings, Mukasey has told senators that he would refuse if the White House asked him to do something he thought was illegal. And he pledged to conduct an independent investigation of those and other policies.

Lawmakers of both parties say they don't have to agree with Mukasey, 66, on every issue. But pressured by their political bases, they'll seek assurances from the nominee that he can be independent of the White House.

"The Justice Department's mission includes advising the other departments and agencies of government, including the president, on what choices they are free to make and what limits they face," Mukasey said. "Here too, the governing standard is what the law and Constitution permit and require."

He quoted former Attorney General Robert Jackson, who said that the issue between authority and liberty was not a choice between a right and a wrong. "That never presents a dilemma," he said. "The dilemma is because the conflict is between two rights - each in its own way important."

In the troubled twilight of Bush's second term, Mukasey's nomination is a political peace offering.

The president nominated him after Schumer suggested that Mukasey would be a suitable replacement for Gonzales - quieting, for the moment, the storm over whether the White House improperly influenced the firings of nine federal prosecutors and other matters.

"There are still some in the administration that want the Department of Justice to be the political arm of the White House," Leahy, D-Vt., said after meeting with Mukasey on Tuesday. "I want that to change, and I think he can change it."

Mukasey once worked as a reporter but gave it up to pursue a career in law. He was nominated to the federal bench in 1987 by President Reagan and eventually became the chief judge of the high-profile U.S. District Court for the Southern District of New York. He played a key role in the courts' response to the Sept. 11 terror attacks, signing material witness warrants to round up Muslim suspects.

---

On the Net:

Senate Judiciary Committee: http://judiciary.senate.gov

White House: http://www.whitehouse.gov/news/releases/2007/09/20070917-4.html

Fish exhibition opens at brlsi

From this great array of Jenyns material, the BRLSI has created a multi-media exhibition, Mr Darwin's Fishes which will beopened on February 12 in the appropriately named Jenyns Room at16-18 Queen Square.

Many of the fish specimens from the Beagle that Jenyns worked onare preserved in spirits at the Natural History Museum in London andare too frail and precious to make the journey to Bath, but theBRLSI's curator, Matt Williams, and his colleagues Jude Harris andPaul Philip Green have captured them on film.

This audio-visual display, using readings from Darwin's lettersand Jenyns's notes, features Bath actor Paul Humpoletz (whorecently played Churchill in the BBC series Behind Closed Doors) as the voice of Jenyns.

The exhibition will be opened on February 12, the date ofDarwin's 200th birthday, with a 'fishy' cake which has beenspecially commissioned to celebrate this iconic date.

The opening ceremony starts at 7pm followed at 7.30pm by a talkentitled From Darwin's Fishes to Jenyns's Fishes. Ichthyology andthe Voyage of the Beagle, given by Dr Daniel Pauly, Professor ofFisheries at the University of British Columbia.

Dr Pauly is one of the best-known fisheries scientists in theworld and is particularly outspoken about global fishing practice.

The exhibition and talk are part of the Darwin and Beyondprogramme at BRLSI in 2009, featuring a wide-ranging series of talksby outstanding speakers throughout the year.

Full details of the programme are available at www.brlsi.org/darwin2009 or from the BRLSI office at 16-18 Queen Square, Bath.

The BRLSI published a book on Leonard Jenyns in 2005 and this hasnow been reissued under the title Leonard Jenyns - Darwin's LifelongFriend.

The book, which contains Jenyns's autobiography as well as aselection of his essays and letters, is available from the BRLSI.

House rejects measure on Guantanamo closing

The House has voted to deny the use of any federal money for the closing of the detention facility at Guantanamo Bay next year and to impose restrictions on the transfer of detainees to the United States.

But House members, in a narrow vote Thursday, defeated a Republican amendment to a 2010 spending bill that would have imposed a more blanket prohibition on the use of any funds related to closing the facility.

The Obama administration had requested $60 million for Justice Department activities in the 2010 budget year related to closing down Guantanamo.

The House already this week passed a $100 billion war-spending bill that bars the use of funds to shut down Guantanamo this year.

Obama announced in January his intention to close the detention center.

___

The bill is

On the Net:

Congress: http://thomas.loc.gov

Nissan issues pathfinder rust repair procedure

To keep you abreast of the latest repair bps and procedures, here are technical service bulletins from carmakers, paint companies and equipment manufacturers.

Some 1987-95 Nissan Pathfinders equipped with V6 engines and fourwheel drive may develop a rust perforation in the floor near the gas pedal. To remedy this problem, Nissan has developed a service procedure that involves replacing the floor sheet metal and installing a different front exhaust pipe.

The first step in the repair is to measure and record the vehicle's front ride height, referring to the appropriate service manual.You will need this as a reference when you reinstall the torsion bar. Next, put the vehicle on a hoist and remove the left side torsion bar, catalytic converter and front propeller shaft. If the vehicle has an automatic transmission, remove the right torsion bar as well. These need to be removed so the new exhaust tube can be installed. Removing them also provides more clearance for the floor repair procedure. (Note: Throughout the procedure, be sure to wear appropriate safety gear, including safety glasses, ear plugs, a respirator and gloves.)

Now support the transmission assembly with the appropriate jack, and take the transmission crossmember off. Remove the O2 sensor, followed by the right and front exhaust tubes-right exhaust manifold flange to catalytic converter flange as an assembly. Reinstall the transmission crossmember now so it is supported during the next several steps. (Caution: Do not allow the weight of the transmission to be supported by the driveshaft resting on the torsion bar crossmember. This can bend the driveshaft.)

Now remove the driver's side front seat assembly and center console, followed by:

* the negative battery cable from the negative battery terminal;

* the kick plate;

* remote glass door/rear hatch lever;

* door weatherstrip;

* dash side trim;

* front floor carpet assembly;

* rear floor heater duct, if applicable;

* body mount flange cover and bolt.

After all of these components are removed, move the wiring harness out of the repair area. Inspect the corroded area and then clean the area to be cut-this includes removing the floor insulation. Ensure that the original spot welds are visible, and draw a chalk outline around the area to be removed (See Fig. 1.), leaving as much of the original sheet metal as possible.

To prepare for the next step, cover all interior panels, the door panel and the wiring harness to protect them from sparks. Now drill out any spot welds located in the material being replaced and cut out the corroded area (See Fig. 2).

From the new body pieces, cut out a panel to patch the opening (See Fig. 3). The cut panel should be 3/4 in. (20 nun) wider than the opening. Flange the edges, and stamp or drill plug-weld holes in the new panel at 15-mm intervals for MIG welding. Using a nylon abrasive pad, wire brush or similar tool, remove all paint, the E-coat and the undercoating along the edges of the opening and the replacement panel. Clean both sides of both panels a minimum of 2 in. from the edge. Next, straighten all mating edges and apply a conductive, anti-corrosive weld-through primer to the floor and new body panel.

Now, check the fit of the new part carefully inside the vehicle (See Fig. 4). Make sure the edges of the new panel match to the metal of the original body with a tight, solid fit and that the frame bolt hole aligns with the hole in the body mount flange. Using a MIG welder, plugweld the replacement panel to the floor (See Fig. 5).

If the lower dash panel is being replaced, include the following steps:

* Remove the left front tire.

* Remove the inner fender liner.

* MIG-weld the panel from the inside of the wheel housing. This will give better structural strength

* Replace removed components after priming and undercoating.

Now, drill two 1/4-in. (7-mm) holes in the floor. Use Fig. 6 as a guide for installing the heat insulator stud bolts. From the interior, install the two stud bolts through the two drilled holes.Weld the bolts to the floor pan-two spots per bolt-using a seam weld. Then remove excess weld metal or slag with a grinder. Install the body mount flange bolt.

Mask off the vehicle-including the stud bolts-to prepare for painting. Apply primer surfacer (DuPont P/N 215S or equivalent) to the repaired area-interior and exterior. Also apply this to the stud bolt holes. Now install the body mount flange bolt plastic cover.

Once the primer dries, apply sealer (Nissan recommends Lord Corp.'s Fusor Urethane sealant P/N 800 or equivalent) to all edges of the repair. (See Fig. 7) After this dries, apply undercoating to the repaired area. Nissan suggests using 3M Rubberized Undercoating P/N 05113508883. Allow the undercoat to dry, and then apply bitumen wax to the repaired underbody area, using only Tectyl 517 Bitumen Wax, Nissan P/N 999MP-9G001.

Now install the new underbody heat shield (See Fig. 8). Apply a sound-deadening material, such as Q-pad or 3M silencer strips P/N 051135-08585, to the repair area (See Fig. 9). Reinstall the vehicle harness, carpeting, driver's seat, center console and all other trim.

Next, support the transmission and remove the crossmember again. Using the "Pathfinder Parts Information" chart, locate the proper part number, install the new front exhaust tube and heat shield assembly and the existing catalytic converter. Following this, install the front propeller shaft, the transmission crossmember, the O2 sensor, torsion bar assembly and torsion bar member. Now adjust the ride height using the procedure and specifications from the service manual. (Caution: Failure to set the proper ride height can result in accelerated tire wear) Reconnect the negative battery cable, and finish the repair by checking the exhaust system for leaks.

If this repair is completed under warranty, Nissan allows 9.8 hours of labor time.

VW Molding Adherence Advice

If the body side molding on 1994-99 Volkswagen Golfs,jettas and Cabrios does not adhere after it's replaced, the problem could be caused by incorrect installation procedures.

Models manufactured before October 1994 featured injection molded-black with fastening clips-body side moldings, Beginning in November, the side moldings were an extruded design.

When installing these extruded moldings, follow these steps:

* Ensure that the working temperature is about 68 deg F (20 deg C).

* Clean exterior panels with isopropyl alcohol, treat with silicone remover and then rub dry.

* If necessary, warm the molding and body surface with a hot air blower before installing. The materials should be warm to the touch.

* Pull the protective foil from the back of the molding and attach molding lightly.

* Press the molding on evenly using a roller. Apply about 10 lbs. of rolling pressure. One complete pass is required for each adhesive strip on the molding.

* Wait at least 24 hours before taking the vehicle through a car wash.

Bonneville Door Tdm Removal Hints

Pontiac is providing technicians with door trim removal procedures and door water deflector installation steps for the 2000 Bonneville.

To remove the trim on the front and rear doors, follow these steps:

* Remove the door handle bezel by prying outboard on the front and then pulling forward to remove the bezel.

* Remove the front side door upper trim (mirror patch) using the J 3877 8 door trim pad and garnish clip. The bezel is attached with one retainer.

* Using the J 38778, disengage all of the push-in retainers and then remove them. Pull upward to remove the trim panel.

* Use needle-nose pliers to remove two spring clips from the metal bracket on the door trim pad.

* Reinsert the spring clips in the plastic retainers on the inner door panel with the flat side of the spring clip facing upward.

* Hold the top of the trim pad away from the top of the door. Align the three lower push pins in the door retainers.

* With all of the pins aligned, set the three lower pins. This automatically aligns the metal clips to the plastic retainers.

* Set all of the remaining clips.

* Push the top of the trim pad outward to set it. This engages the top of the trim pad over the inner belt retaining flange.

* Install the door handle bezel and the front side door upper trim (mirror patch).

When service is required to the vehicle's water deflector, which directs water away from the inner panel, make sure it is re-installed properly.The correct installation steps for front and rear doors are:

* Install the inner water deflector after the glass but before the inner belt seal.

* Insert the deflector through the belt line. It must be inboard of the door glass.

* Position the deflector against the mirror patch.

* Fold the perforated portion of the deflector over the inner belt retaining flange. Press on it to secure it.

Whenever service procedures require the water deflector to be "disturbed," the piece must be properly resealed to the door panel to prevent water leaks. To reseal the piece, clean the door surface around the perimeter of the water deflector with one of these cleaners or an equivalent product: 3M General Purpose Adhesive Cleaner; Dominion Sure Seal Sure Solve Stock BSS; Kent Acrysol.

Next, use a 2 in. wallpaper roller to roll out the butyl adhesive. (Note: The door surface must be at room temperature,) Now, start at the bottom center and work outboard up the right and left sides.

Prevent Buick Mirror Breakage

During repairs to 1997-99 Buick Park Avenues and Ultras, technicians may damage the power pack crossmember on the side mirrors.

To prevent this when removing left side assemblies, apply thumb pressure to the inboard side of the mirror glass and case assembly and pull from the bottom corner of the outboard side of the mirror glass and case assembly until it "snaps away" from the power pack.

When removing right side components, apply thumb pressure to the inboard side and pull from the top corner of the outboard side until the mirror and case assembly let go.